177 related articles for article (PubMed ID: 35534064)
1. Characteristics of registered and published systematic reviews focusing on the prevention of COVID-19: a meta-research study.
Nothacker J; Stadelmaier J; Siemens W; Meerpohl JJ; Schmucker C
BMJ Open; 2022 May; 12(5):e060255. PubMed ID: 35534064
[TBL] [Abstract][Full Text] [Related]
2. Three out of four published systematic reviews on COVID-19 treatments were not registered and one-third of those registered were published: a meta-research study.
Siemens W; Nothacker J; Stadelmaier J; Meerpohl JJ; Schmucker C
J Clin Epidemiol; 2022 Dec; 152():36-46. PubMed ID: 36179937
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.
Gianola S; Jesus TS; Bargeri S; Castellini G
PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014
[TBL] [Abstract][Full Text] [Related]
4. A descriptive analysis of the characteristics and the peer review process of systematic review protocols published in an open peer review journal from 2012 to 2017.
Rombey T; Allers K; Mathes T; Hoffmann F; Pieper D
BMC Med Res Methodol; 2019 Mar; 19(1):57. PubMed ID: 30866832
[TBL] [Abstract][Full Text] [Related]
5. The score after 10 years of registration of systematic review protocols.
van der Braak K; Ghannad M; Orelio C; Heus P; Damen JAA; Spijker R; Robinson K; Lund H; Hooft L
Syst Rev; 2022 Sep; 11(1):191. PubMed ID: 36064610
[TBL] [Abstract][Full Text] [Related]
6. Registration of systematic reviews in PROSPERO: 30,000 records and counting.
Page MJ; Shamseer L; Tricco AC
Syst Rev; 2018 Feb; 7(1):32. PubMed ID: 29463298
[TBL] [Abstract][Full Text] [Related]
7. Inconsistencies in study eligibility criteria are common between non-Cochrane systematic reviews and their protocols registered in PROSPERO.
Hu K; Zhao L; Zhou Q; Mei F; Gao Q; Chen F; Jiang M; Zhao B; Zhang W; Kwong JSW; Ma Y; Mou C; Ma B
Res Synth Methods; 2021 May; 12(3):394-405. PubMed ID: 33522101
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of systematic reviews evaluating treatments for COVID-19 registered in PROSPERO.
Zhang R; Gao Y; Xie D; Lian R; Tian J
Epidemiol Infect; 2021 Jun; 149():e146. PubMed ID: 34130770
[TBL] [Abstract][Full Text] [Related]
9. Transparency and reporting characteristics of COVID-19 randomized controlled trials.
Kapp P; Esmail L; Ghosn L; Ravaud P; Boutron I
BMC Med; 2022 Sep; 20(1):363. PubMed ID: 36154932
[TBL] [Abstract][Full Text] [Related]
10. Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study.
Oikonomidi T; Boutron I; Pierre O; Cabanac G; Ravaud P;
BMC Med; 2020 Dec; 18(1):402. PubMed ID: 33334338
[TBL] [Abstract][Full Text] [Related]
11. Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study.
Abbott R; Bethel A; Rogers M; Whear R; Orr N; Shaw L; Stein K; Thompson Coon J
BMJ Evid Based Med; 2022 Jun; 27(3):169-177. PubMed ID: 34083212
[TBL] [Abstract][Full Text] [Related]
12. Extent and nature of duplication in PROSPERO using COVID-19-related registrations: a retrospective investigation and survey.
Beresford L; Walker R; Stewart L
BMJ Open; 2022 Dec; 12(12):e061862. PubMed ID: 36456005
[TBL] [Abstract][Full Text] [Related]
13. The mass production of systematic reviews about COVID-19: An analysis of PROSPERO records.
Dotto L; Kinalski MA; Machado PS; Pereira GKR; Sarkis-Onofre R; Dos Santos MBF
J Evid Based Med; 2021 Feb; 14(1):56-64. PubMed ID: 33595200
[TBL] [Abstract][Full Text] [Related]
14. More systematic reviews were registered in PROSPERO each year, but few records' status was up-to-date.
Rombey T; Doni K; Hoffmann F; Pieper D; Allers K
J Clin Epidemiol; 2020 Jan; 117():60-67. PubMed ID: 31589953
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, methodological quality, and reporting characteristics of systematic reviews and meta-analyses on coronavirus disease 2019: A cross-sectional study.
Chen Y; Li L; Zhang Q; Liu H; Huang Y; Lin S; Yin G; Xie Q
Medicine (Baltimore); 2021 Nov; 100(47):e27950. PubMed ID: 34964777
[TBL] [Abstract][Full Text] [Related]
16. PROSPERO's systematic review protocols of traditional Chinese medicine for COVID-19: An overview.
Hu H; Ji Z; Feng C; Pang W; Chen Z; Zhang J; Wang H
Integr Med Res; 2021; 10(Suppl):100774. PubMed ID: 34518798
[TBL] [Abstract][Full Text] [Related]
17. Sexual transmission of SARS-CoV-2 virus and its role in the spread of COVID-19: A living systematic review protocol.
Duarte G; Ortiz-Muñoz L; Morales MB; Acuña MP; Rada G;
Medwave; 2020 Nov; 20(10):e8062. PubMed ID: 33361754
[TBL] [Abstract][Full Text] [Related]
18. Characteristics, completion and publication of PROSPERO records in regional anesthesia for acute perioperative pain.
Carev M; Čivljak M; Puljak L; Došenović S
J Comp Eff Res; 2023 Mar; 12(3):e220129. PubMed ID: 36688587
[No Abstract] [Full Text] [Related]
19. Unpublished systematic reviews and financial support: a meta-epidemiological study.
Tsujimoto H; Tsujimoto Y; Kataoka Y
BMC Res Notes; 2017 Dec; 10(1):703. PubMed ID: 29208054
[TBL] [Abstract][Full Text] [Related]
20. Redundant systematic reviews on the same topic in surgery: a study protocol for a meta-epidemiological investigation.
Katsura M; Kuriyama A; Tada M; Yamamoto K; Furukawa TA
BMJ Open; 2017 Aug; 7(8):e017411. PubMed ID: 28827269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
